Background: Choline and betaine are found in a variety of plant and animal foods and were recently shown to be associated with decreased homocysteine concentrations. Objective: The scope of this work was to investigate the associations between dietary choline and betaine consumption and various markers of low-grade systemic inflammation. Design: Under the context of a cross-sectional survey that enrolled 1514 men (18 -87 y of age) and 1528 women (18 -89 y of age) with no history of cardiovascular disease (the ATTICA Study), fasting blood samples were collected and inflammatory markers were measured. Dietary habits were evaluated with a validated foodfrequency questionnaire, and the intakes of choline and betaine were calculated from food-composition tables. Results: Compared with the lowest tertile of choline intake (250 mg/d), participants who consumed 310 mg/d had, on average, 22% lower concentrations of C-reactive protein (P 0.05), 26% lower concentrations of interleukin-6 (P 0.05), and 6% lower concentrations of tumor necrosis factor-␣ (P 0.01). Similarly, participants who consumed 360 mg/d of betaine had, on average, 10% lower concentrations of homocysteine (P 0.01), 19% lower concentrations of C-reactive protein (P 0.1), and 12% lower concentrations of tumor necrosis factor-␣ (P 0.05) than did those who consumed 260 mg/d. These findings were independent of various sociodemographic, lifestyle, and clinical characteristics of the participants. Conclusions: Our results support an association between choline and betaine intakes and the inflammation process in free-eating and apparently healthy adults. However, further studies are needed to confirm or refute our findings.
INTRODUCTION
Choline is a component found in a variety of foods of both animal (eg, liver, eggs, pork, beef, cod, shrimp, and salmon) and plant (eg, dried soybeans, oat bran, Brussels sprouts, broccoli, and cauliflower) origin (1) . It can be also endogenously synthesized in the liver from phosphatidylethanolamine, a reaction catalyzed by phosphatidylethanolamine N-methyltransferase with S-adenosylmethionine acting as a methyl donor. However, humans following a diet deplete of choline can develop signs of deficiency (2) . Betaine, a derivative of choline, can be found in dietary sources such as wheat germ, spinach, shrimp, wheat bread, and raw mushrooms (1) . Although choline was discovered almost 150 y ago, it was not until 1998 that the Institute of Medicine listed it as an essential nutrient and emphasized the need to further study the "effects of choline intake to health parameters" (3) . This quaternary amine serves as a structural constituent of membrane phospholipids, such as phosphatidylcholine, choline plasmalogens, and sphingomyelin (3) . Other biological actions of choline include cholinergic neurotransmission, platelet-activating-factor formation, hepatic secretion of VLDLs, and methyl transport (3) . Indeed, choline can act as a methyl donor through its intermediate oxidation to betaine, which can subsequently convert homocysteine to methionine. Alternatively, methionine synthase methylates homocysteine by using folate (3) . Apart from remethylation, homocysteine can also follow the transsulfuration pathway, which leads to its conversion to cystathionine in a reaction catalyzed by cystathionine ␤-synthase with vitamin B-6 as a cofactor (3) . Betaine functions as an osmolyte and as a methyl donor in many pathways, including the methylation of homocysteine (4) .
Low-grade inflammation is generally recognized as a central step in the pathogenesis of atherosclerosis (5) . Moreover, established inflammatory biomarkers, such as C-reactive protein, interleukin-6, and tumor necrosis factor-␣ (6), have been connected to the risk of cardiovascular events (7-9) with some exceptions (10) . Homocysteine, a risk factor for cardiovascular disease (11) has also been shown to be related to inflammation (11) and atherosclerosis by being involved in endothelial dysfunction, lipoprotein oxidation, platelet activation, collagen synthesis (12) , and cytokine regulation (13) .
The close relation between inflammation and atherosclerosis implies that measures designed to reduce the inflammatory response could be beneficial. There is some evidence that B vitamins involved in methyl transport are linked to the inflammation state (14, 15) . Given that choline has been found to blunt cytokine concentrations in animal models (16) and is involved in methyl transport through its oxidation to betaine (3), it would be interesting to test whether choline and betaine intake from the diet are related to inflammation.
To our knowledge there is no epidemiologic study connecting dietary intake of choline and betaine with inflammatory indexes. Therefore, the aim of the present work was to investigate the associations between dietary choline and betaine consumption and C-reactive protein, interleukin-6, tumor necrosis factor-␣, and homocysteine in apparently healthy individuals from the ATTICA study (17) .
SUBJECTS AND METHODS

Subjects
The ATTICA epidemiologic study (17) has been carried out in the province of Attica (including 78% urban and 22% rural areas). From May 2001 to December 2002, 4056 free-living inhabitants from the Attica area with no history of cardiovascular or any other atherosclerotic disease, no chronic viral infections, no cold or flu, no acute respiratory infection, no dental problems, and no history of surgery in the past week were randomly selected to enroll in the study; 3042 agreed to participate (75% participation rate). All participants were interviewed by trained personnel (cardiologists, general practitioners, dietitians, and nurses) who used a standard questionnaire.
Power analysis showed that the number of enrolled participants is adequate to evaluate 2-sided standardized differences between tertiles of choline and betaine intakes and the investigated inflammatory indexes 0.5, achieving a statistical power 0.90 at a 5% probability level (P value). The study was approved by the Medical Research Ethics Committee of the supervised Institution and was carried out in accordance with the Declaration of Helsinki (1989) of the World Medical Association.
Dietary assessment
The dietary intake was assessed in all participants with a validated semiquantitative food-frequency questionnaire (ie, the EPIC-Greek) with attached pictures representing different portion sizes (18) . The daily choline and betaine intakes were calculated by a registered dietitian for each food item based on the grams of food consumed per day multiplied by the choline or betaine content per gram of the same food. For composite traditional Greek dishes, widely accepted published recipes were considered (19) and then the total choline or betaine content of each dish was calculated as the sum of choline or betaine content of its ingredients. The values for the choline and betaine contents of foods were based on those provided by the US Department of Agriculture (1).
Sociodemographic and lifestyle variables
We recorded the mean annual income during the past 3 y and the educational level of the participants in years of school (as proxies of socioeconomic status). Current smokers were defined as those who smoked at least one cigarette per day. Occasional smokers (7 cigarettes smoked/wk) were recorded and combined with current smokers because of their small sample size. The International Physical Activity Questionnaire was used to ascertain physical activity status (20) -an index of weekly energy expenditure based on frequency (times/wk), duration (min/ time), and intensity of sports-related physical activity. Participants who reported no physical activities were defined as sedentary, whereas the rest were considered physically active. Height and weight were recorded, and body mass index (BMI) was calculated (weight in kg/height in m 2 ).
Clinical and biochemical characteristics
Resting arterial blood pressure was measured 3 times in the right arm at the end of the physical examination while the subjects were in sitting position. Fasting blood samples were collected between 0800 and 1000. The biochemical evaluation was carried out in the same laboratory, which followed the criteria of the World Health Organization Reference Laboratories. C-reactive protein was assayed in all participants by particleenhanced immunonephelometry (N Latex; Dade Behring Marburg GmbH, Marburg, Germany) with a range from 0.175 to 1100 mg/L. Interleukin-6 was measured in all participants with a high-sensitivity enzyme-linked immunosorbent assay (ELISA; R & D Systems Europe Ltd, Abingdon, United Kingdom) with a range from 0.156 to 10 pg/mL. The intraassay and interassay CVs were 5% for C-reactive protein and 10% for interleukin-6. Homocysteine was measured in 2200 participants according to the pulsar fluorescence method (Abbott Axsym; Diamond Diagnostics, Holliston, MA), and the CV was 5% (21) . We used the ELISA method for the quantitative determination of human tumor necrosis factor-␣ in duplicate in serum samples of 2540 participants by Quantikine HS/human tumor necrosis factor-␣ immunoassay kit (R & D Systems Inc, Minneapolis, MN), and the CV was 7%. Serum total cholesterol was measured in all participants according to the chromatographic enzymatic method in a Technicon automatic analyzer (RA-1000; Dade Behring Marburg GmbH). The intra-and interassay CVs of cholesterol concentrations did not exceed 3%. Patients whose average blood pressure levels were ͧ140/90 mm Hg or who were taking antihypertensive medication were classified as being hypertensive. Hypercholesterolemia was defined as a total serum cholesterol concentration 200 mg/dL or the use of lipidlowering agents. Diabetes mellitus was defined as a fasting blood glucose 125 mg/dL or the use of antidiabetic medication.
Statistical analysis
Continuous variables are presented as means Ȁ SDs, whereas categorical variables are presented as relative frequencies (%). Comparisons between inflammation variables and tertiles of betaine or choline intake were performed by analysis of variance (ANOVA), whereas differences in categorical variables between nutrients' tertiles were performed by using the Z test. However, because of multiple comparisons we used the Bonferroni correction to account for the increase in type I error. Finally, generalized univariate regression models were applied to test the association of inflammatory markers by choline and betaine intake group. Because of their skewed distributions, C-reactive protein and homocysteine values were log transformed. All reported P values are based on 2-sided tests and compared with a significance level of 5%. SPSS 14 (SPSS Inc, Chicago, IL) software was used for all the statistical calculations.
RESULTS
Mean daily choline intake was 291 Ȁ 79 mg in men and 285 Ȁ 75 mg in women (P ҃ 0.26), whereas the range of intake CHOLINE, BETAINE CONSUMPTION, AND INFLAMMATION varied from 72 to 852 mg in men and from 126 to 740 mg in women. The major sources of choline and betaine as well as the intake of these foods by the ATTICA Study participants are shown in Table 1 .
The various sociodemographic, lifestyle, and clinical characteristics of the participants by choline intake group are shown in Table 2 . Subjects with higher choline intakes consumed more servings of fruit, vegetables, legumes, and red meat per week. Moreover, the percentage of hypercholesterolemic subjects was significantly smaller in the highest than in the lowest tertile of choline intake.
The various characteristics of the participants by betaine intake group are shown in Table 3 . Daily betaine intake was 306 Ȁ 118 mg in men and 314 Ȁ 105 mg in women (P ҃ 0.22); the range of daily intake was between 52 and 1120 mg in men and 79 and 681 mg in women. Subjects with higher betaine intake were older, were more physically active, and consumed more servings of fruit, vegetables, legumes, and red meat per week. Moreover, the proportion of hypercholesterolemic subjects was significantly greater in the highest than in the lowest tertile of betaine intake. Note that sex, ethanol intake, BMI, socioeconomic status, and the presence of diabetes or hypertension were not differentiated by either choline or betaine intake.
Despite the significant associations observed in univariate analysis, residual confounding may exist. Thus, we adjusted for various potential confounders, such as age, sex, current smoking habits, physical activity status, BMI, and the presence and treatment of various clinical characteristics that have been reported to influence inflammatory markers (eg, diabetes, hypertension, and hypercholesterolemia) (22, 23) . However, we were not able to adjust for dietary folate and other B vitamins, which are involved in homocysteine metabolism, because these values were not calculated from the questionnaire we used. We did not adjust for dietary methionine intake because its usual fluctuations do not change fasting homocysteine concentrations (24) . The results of fixed-effects generalized linear models that evaluated the association of daily choline and betaine intakes with concentrations of homocysteine, C-reactive protein, interleukin-6, and tumor necrosis factor-␣ are shown in Table 4 . Compared with the lowest choline intake, participants who consumed 310 mg/d had, on average, 22% lower concentrations of C-reactive protein (P 0.05), 26% lower concentrations of interleukin-6 (P 0.05), and 6% lower concentrations of tumor necrosis-␣ (P 0.01). Similarly, participants who consumed 360 mg/d of betaine had, on average, 10% lower concentrations of homocysteine (P 0.01), 19% lower concentrations of C-reactive protein (P 0.1), and 12% lower concentrations of tumor necrosis-␣ (P 0.05), whereas no association was observed between betaine intake and interleukin-6 concentrations. It should be added that the aforementioned findings were irrespective of the various lifestyle and clinical characteristics of the participants.
Finally, we created 4 subgroups of subjects according to dietary choline and betaine intakes from the diet. One group consisted of individuals who had low dietary daily choline and betaine intakes (ie, lower tertiles), and the other groups consisted of persons with high choline and low betaine, low choline and high betaine, or high choline and high betaine intakes. After adjustment for the aforementioned confounders, we showed that individuals in the highest tertiles of betaine and choline had lower concentrations of homocysteine, interleukin-6, and tumor necrosis factor-␣ than did all other groups, whereas a high choline and low betaine intake was associated with the lowest C-reactive protein concentrations (Table 5) . Furthermore, high choline, high betaine, or high choline and high betaine intakes were independently associated with lower concentrations of tumor necrosis factor-␣ than were low intakes of these nutrients (P 0.05).
DISCUSSION
To our knowledge we are the first to show that a diet rich in choline and betaine is associated with inflammation after multivariate adjustment for various sociodemographic, lifestyle, and clinical characteristics of the subjects. Moreover, the combination of a high dietary intake of choline and betaine was associated with lower concentrations of all the investigated inflammatory markers, which is in accordance with the results of Cho et al (25) concerning the combined effect of dietary intakes of choline and betaine on homocysteine concentrations.
Dietary intakes of choline and betaine
There are few epidemiologic studies concerning the relation between dietary choline or betaine intake and health variables (25) (26) (27) , given that food databases for these compounds were not available until recently (1) . Choline in foods can be free or bound as esters such as phosphocholine, glycerophosphocholine, sphingomyelin, and phosphatidylcholine (28) . We assessed the total choline intake because discrepancies may exist when calculating the choline content of whole dishes based on the values of individual food items. It has been found that cooking does not change the total choline content of foods, but it can affect choline fractions (free choline is increased and phosphatidylcholine is decreased with cooking) (28) . In this context we considered the total choline intake to be more accurate than individual choline forms. Mean choline intake was similar to the results of others who also used a food-frequency questionnaire (25) (26) (27) 29) , lower compared with the results of an observation study (30) , and below the adequate intake set by the Institute of Medicine (3). The estimated betaine intake in our study was higher than that recently published in other studies (25) (26) (27) 29) . A possible explanation for this difference is that the food-frequency questionnaire we used included 4 separate questions for spinach and traditional spinach containing Greek dishes (spinach, spinach with rice, spinach pie, and "leafy vegetables" pie) (18) ; given the high betaine concentration of spinach (28), higher values may have been found. No comparison with dietary recommendations could be made because no dietary reference intake has been set for betaine.
We found in the unadjusted analysis that a greater proportion of subjects in the highest tertile than in the lowest tertile of choline intake were hypercholesterolemic. The opposite trend was observed for subjects with a high betaine intake. Dalmeijer et al (26) found that subjects with a higher betaine intake had a lower HDL-cholesterol concentration and subjects with a higher choline intake had a higher HDL-cholesterol concentration, whereas results from intervention studies have shown that high doses of both betaine and choline intake can adversely affect blood lipids (31, 32) .
Inflammation markers in relation to choline and betaine intakes
The relation between low-grade inflammation and diet is still evolving. Supplementation of healthy subjects with B vitamins, which are involved in homocysteine metabolism, can lower concentrations of inflammatory molecules (15, 33) , with some exceptions (34) . Paradoxically, secondary intervention trials with B vitamin have shown homocysteine lowering, but seem rather unsuccessful in attenuating inflammatory indexes (35, 36 )-a result that may be attributed to the presence of irreversible atheromatous lesions in the high-risk participants or to the difficulty in achieving additive benefits if patients are already under pharmacologic treatment. Choline (37) and betaine supplements have been found to decrease homocysteine concentrations (38, 39) , and betaine is widely used for the treatment of homocystinuria (4). Higher dietary intake of choline (25, 26) and betaine (25) have recently been connected to lower homocysteine concentrations, whereas such an association was not confirmed for choline in our study.
As far as dietary choline is concerned, it is noteworthy that any possible effects on the measured biochemical markers are more difficult to isolate because they may be differentiated by the intake of choline subfractions (25) and masked by complex interrelations between phospholipids (28). Moreover, the endogenous synthesis of the phosphatidylcholine molecule via phosphatidylethanolamine can lead to the production of homocysteine molecules (40) and, thus, may alter any possible diet-related changes in homocysteine.
The facts that the dietary intake of choline showed no association with homocysteine, that the interrelation of homocysteine and C-reactive protein was not confirmed in intervention trials (35, 36, 41) , and that the investigated dietary components have additional actions in animal studies (eg, prevent macrophage activation, reduce nuclear factor -B) (16) suggest that homocysteine may not be the only mechanism through which dietary betaine and choline are associated with inflammation.
In this context, it can be hypothesized that both dietary choline (42) and betaine (43) can attenuate inflammatory response by increasing S-adenosylmethionine (SAM) and reducing S-adenosylhomocysteine (SAH), the ratio of which regulates the activities of most methyltransferases. An elevation of SAM can prevent the induction of inducible nitric oxide synthase (44) , attenuate the production of nuclear factor -B (45), and increase the production of glutathione (46) , which in turn is involved in cytokine regulation (47) . Moreover, SAM activates cystathionine ␤-synthase, which irreversibly converts homocysteine to cystathionine in selected tissues (48) . Cystathionine can be further metabolized to cysteine and glutathione (48) . A decrease in SAH would also be favorable given that it can be converted to homocysteine (43) . Furthermore, products of both betaine (49) and choline (47) metabolism (eg, serine and glycine) can be used in glutathione synthesis, whereas only choline has also been proposed to be involved in intracellular signaling (16) , which is related to inflammatory response. Whatever mechanism underlies our findings, it is important that the magnitude of the observed differences concerning the concentrations of inflammatory indexes between the subjects in the highest compared with the lowest tertile of dietary choline or betaine intake is similar to those observed in subjects following the Mediterranean diet (50) or consuming high amounts of nҀ3 fatty acids (51) . Using our results as a starting point, one can hypothesize that a higher intake of choline and betaine from the diet might be protective against inflammation and related diseases. However, it is worth referring to 2 recent large-scale studies-the Prospect-EPIC (European Prospective Investigation into Cancer and Nutrition) cohort, which showed no relation of choline or betaine intake with cardiovascular disease risk (26) , and the Atherosclerosis Risk in Communities (ARIC) study, which found no relation between dietary choline or choline plus betaine and incident coronary heart disease (27) . A factor masking a possible relation of choline or betaine with the examined endpoints may be the relatively low range of choline and betaine intakes, as the authors suggest (26) . Moreover, in the EPIC cohort, only 4.4% of the recruited subjects had a diagnosis of cardiovascular disease (26), a relatively low proportion that may have attenuated any possible correlation between dietary intake of the examined dietary components and cardiovascular disease.
Some limitations of our study have to be considered along with the interpretation of our results. The ATTICA study was crosssectional; therefore, it could not establish causal relations but could only generate a hypothesis. Thus, to prove causality, randomized trials must be carried out. The misreporting of various food items consumed can be a potential confounder. Another limitation is that we calculated choline and betaine intakes through international, not national, food-composition tables. This may reflect the calculation of the amount of actual choline and betaine intakes concentrated in the foods usually consumed in Greece. Thus, to moderate the potential bias, we used tertiles of choline and betaine intakes, instead of quantitative variables.
In conclusion, the present study was the first to show a relation between inflammation and dietary intake of choline and betaine in a free-eating, population-based sample of cardiovascular disease-free adults. In particular, we found that a greater intake of these compounds from the diet was independently associated with a reduction in inflammation indexes that are believed to have an important role in cardiovascular disease. Nevertheless, because of the cross-sectional design of the present study, further randomized clinical trials are needed to confirm or refute our finding.
